Predictive Factors of Eribulin Activity in Metastatic Breast Cancer Patients.
De Sanctis R, Agostinetto E, Masci G, Ferraro E, Losurdo A, Viganò A, Antunovic L, Zuradelli M, Torrisi RMC, Santoro A.
De Sanctis R, et al. Among authors: masci g.
Oncology. 2018;94 Suppl 1(Suppl 1):19-28. doi: 10.1159/000489065. Epub 2018 Jul 23.
Oncology. 2018.
PMID: 30036884
Free PMC article.